Highlights
A collection of news and information related to Lilly Eli & Co published by this site and its partners.
Displaying items 1-12 of 222
» View baltimoresun.com items only
1
2
3
4
5
6
7
8
9
10
11-19
•
Next >
-
FDA approves new drug for erectile dysfunction
Men now have a new option to treat erectile dysfunction. The U.S. Food and Drug Administration has approved the new drug Stendra to treat the illness that causes problems in the sex lives of 30 million men. It is the first erectile dysfunction drug in a...Tags: High Blood Pressure, Pfizer Inc., Food and Drug Administration, Drug Trafficking, Chemicals
-
Getting to Alzheimer's roots
The end for the Alzheimer's patient is a horror: The person is mute, bedridden, adrift from the thoughts and feelings that make up a life. The brain undergoes an equally disturbing transformation, shrunken by as much as half, mottled all over with...Tags: Medical Research, Aging, Rita Hayworth, Symptoms, Colleges and Universities
-
Dow soars to second triple-digit gain
Associated PressA burst of buying swept across the stock market Wednesday, giving the Dow Jones industrials their second triple-digit gain for the first time in nearly three months. After a session spent vacillating between modest gains and losses, the market began to...Tags: Best Buy Company Inc., Merrill Lynch & Company Inc., Goldman Sachs, Broadcom Corp., Watson Pharmaceuticals Incorporated
-
Reuters Health News Summary
ReutersFollowing is a summary of current health news briefs. Sanofi, Novo, Lilly shape up for big insulin fight LONDON (Reuters) - Competition is ramping up in the multibillion-dollar market for long-lasting insulins, with Novo Nordisk and Eli Lilly lining...Tags: Medical Research, Diabetes, Internists, Chemicals, Lantus (drug)
-
Sanofi, Novo, Lilly se alistan para gran lucha mercado insulinas
Reuters* Productos de Novo y Lilly desafiarán dominio de Sanofi * Nuevas insulinas acción prolongada irán por líder Lantus * Ventas Lantus llegarán a cerca de 7.000 mlns dlrs en 2015 Por Ben Hirschler LONDRES, 29 mayo (Reuters) - La competencia en el...Tags: Diabetes, Byetta (drug), Lantus (drug), Deutsche Bank AG
-
Sanofi, Novo, Lilly shape up for big insulin fight
Reuters* Novo and Lilly products to challenge Sanofi's dominance * New long-acting insulins may trump market-leading Lantus * Lantus sales seen peaking at close to $7 bln in 2015 By Ben Hirschler LONDON, May 29 (Reuters) - Competition is ramping up in the...Tags: Insulin, New Products, Diabetes, Weight, Byetta (drug)
-
UPDATE 1-Europe endorses new Vertex drug for cystic fibrosis
Reuters* Kalydeco recommended by European Medicines Agency * Follows approval in U.S. market in January (Adds details on Kalydeco, background) LONDON, May 25 (Reuters) - Vertex Pharmaceuticals Inc's new cystic fibrosis drug Kalydeco was recommended for...Tags: Lungs and Airways, Symptoms, Renal cell carcinoma, Europe, Genetic Condition
-
ANALYSIS-Drugmakers vulnerable if US health law revoked
Reuters* Overturning law may revive more ambitious proposals to cut costs * Some question existing drugmaker deal under the law * Sector stocks could see short-term gain, but risks heightened By Deena Beasley LOS ANGELES, May 24 (Reuters) - Pharmaceutical...Tags: Amgen Inc., Medical Research, Technology, Patents, Copyrights and Trademarks, Barack Obama
-
Eli Lilly clothing drive to benefit Goodwill ends Thursday
The donations are piling up for Goodwill stores in Central Indiana. Eli Lilly will wrap up a clothing drive Thursday. Employees donated dozens of bags of clothes. This drive has been going on for 20 years now, helping Goodwill employ and educate people....
-
Fármaco de Eli Lilly para la diabetes cumple meta en ensayo
Reuters22 mayo (Reuters) - Un medicamento experimental del laboratorio Eli Lilly and Co para tratar la diabetes tipo 2 cumplió la meta principal de un ensayo en estadio intermedio que evaluó su efecto sobre la presión sanguínea y el ritmo cardíaco. A los...Tags: Diabetes, Placebo
-
Eli Lilly's diabetes drug meets mid-stage trial goal
Reuters(Reuters) - Drugmaker Eli Lilly and Co's experimental drug to treat type 2 diabetes met the main goal of a mid-stage trial to test its effect on blood pressure and heart rate. The results of the study showed that the effect of Lilly's drug, dulaglutide,...Tags: High Blood Pressure, Diabetes, Chemicals, Stock Market, NYSE
-
Firms pray for 'yes' in Irish EU treaty referendum
Reuters* Irish Business group gets backing in "Yes" campaign * U.S. firms say vote is key factor in possible investments * Employers warn rejection will see Ireland go way of Greece * Minority say "No" vote would be clear signal on debt woes By Padraic...Tags: Republic of Ireland, Europe, Finance, Dundalk, Referenda
Apr 30, 2012
|Story| Baltimore Sun
Apr 17, 2002
|Story| Baltimore Sun
Aug 7, 2002
|Story| Associated Press
May 29, 2012
|Story| Reuters
May 29, 2012
|Story| Reuters
May 29, 2012
|Story| Reuters
May 25, 2012
|Story| Reuters
May 24, 2012
|Story| Reuters
May 23, 2012
|Column| WXIN-LTV
May 22, 2012
|Story| Reuters
May 22, 2012
|Story| Reuters
May 17, 2012
|Story| Reuters
Original site for Lilly Eli & Co topic gallery.
